22 June 2024 in Phenomics
Pyroptosis is a newly recognized type of programmed cell death mediated by the gasdermin family and caspase. It is characterized by the formation of inflammasomes and the following inflammatory responses. Recent studies have elucidated the value of pyroptosis induction in cancer treatment. The inflammatory cytokines produced during pyroptosis can trigger immune responses to suppress malignancy. Physical approaches for cancer treatment, including radiotherapy, light-based techniques (photodynamic and photothermal therapy), ultrasound-based techniques (sonodynamic therapy and focused ultrasound), and electricity-based techniques (irreversible electroporation and radiofrequency ablation), are effective in clinical application. Recent studies have reported that pyroptosis is involved in the treatment process of physical approaches. Manipulating pyroptosis using physical approaches can be utilized in combating cancer, according to recent studies. Pyroptosis-triggered immunotherapy can be combined with the original anti-tumor methods to achieve a synergistic therapy and improve the therapeutic effect. Studies have also revealed that enhancing pyroptosis may increase the sensitivity of cancer cells to some physical approaches. Herein, we present a comprehensive review of the literature focusing on the associations between pyroptosis and various physical approaches for cancer and its underlying mechanisms. We also discussed the role of pyroptosis-triggered immunotherapy in the treatment process of physical manipulation.
10 October 2025 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Preoperative lymphatic vessel mapping is essential for lymphaticovenous anastomosis (LVA). This study compared high-frequency ultrasound (HFUS) and indocyanine green (ICG) fluorescent lymphography in preoperative localization for enhancing precision in functional lymphatic vessel identification through ultrasound to provide precise imaging guidance for surgical success. We retrospectively reviewed patients who underwent LVA treatment for unilateral lower limb lymphedema between January 2024 and December 2024. By analyzing their imaging findings, clinical data, and surgical records, we compared the accuracy and efficacy (comparison of preoperative and postoperative volume) of HFUS versus ICG lymphography in preoperative lymphatic vessel mapping for LVA, as well as their impact on operative duration. One hundred patients with secondary lower limb lymphedema were divided into 2 groups: 50 received HFUS-guided lymphatic mapping (HFUS group), and 50 underwent ICG fluorescent lymphography (ICG group). The HFUS group reported 236 lymphatic vessels, whereas the ICG group reported 183. Localization accuracy was 95.05% for HFUS and 84.73% for ICG (p < 0.001). At 1-week postoperatively, postoperative volume reduction was 7.35 ± 2.09% for HFUS and 5.89 ± 1.59% for ICG (p < 0.001), and mean operative times were 2.00 ± 0.58 h for HFUS and 2.15 ± 0.55 h for ICG (p < 0.001). The HFUS group was more accurate and effective than the ICG group, and could find more functional lymphatic vessels, help reduce the operation time, and improve the operation efficiency.
1 September 2026 in Journal of Clinical Ultrasound